ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Santen Pharmaceutical Co., Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 94 studies whose lead sponsor is Santen Pharmaceutical Co., Ltd. or one of 8 companies grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 28, 2026.

Our grouping of 9 registry names, not the registry’s. See them and correct one ↓

Pipeline: 1 program

Each counted once: 1 with a study Santen Pharmaceutical Co., Ltd. leads registered in the last two years.

  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Santen Pharmaceutical Co., Ltd.’s own registered studies; Santen Pharmaceutical Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Santen Pharmaceutical Co., Ltd.’s studies test, most open studies first — 24 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 14 more

Coming up

1 of Santen Pharmaceutical Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 94 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now33%
  • Under way, not recruiting22%
  • Completed8388%
  • Stopped early44%
  • Status unknown or other22%

Phase

  • Phase 337
  • Phase 233
  • Phase 115
  • Phase 45
  • Early Phase 11

Where

  • United States39
  • Japan23
  • France17
  • Italy10
  • Spain10
  • United Kingdom7

Over the years

  1. 07
  2. 1008
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started; 3 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Santen Pharmaceutical Co., Ltd.

  • Santen Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    32 studies →
  • Santen Pharmaceutical Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    30 studies
  • Santen SAS
    Acquired — became part of Santen Pharmaceutical Co., Ltd., Oct 11, 2011 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    14 studies →
  • Santen Oy
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • InnFocus Inc.
    Acquired — became part of Santen Pharmaceutical Co., Ltd., Aug 19, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Santen Pharmaceutical (Taiwan) Co., LTD
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Santen Pharma Malaysia Sdn Bhd
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Santen Pharmaceutical(China) Co.,LTD
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Santen Pharmaceutical Asia Pte. Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Santen Pharmaceutical Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 94. Browse all 94 →